(Circulation. 2001;104:1757.)
© 2001 American Heart Association, Inc.
Brief Rapid Communications |
From the Department of Obstetrics and Gynecology, Division of Prenatal Medicine, University of Lübeck, Lübeck, Germany (T.K.); the Departments of Anesthesiology (M.W., D.S., H.V.A.), Pediatric Cardiology (T.K., S. Achenbach, S.H., S. Aryee, T.B., R.A., J.V.), Cardiothoracic Surgery (B.A., H.H.S.), and Obstetrics and Gynecology (R.W.), University of Münster, Münster, Germany; and Gütersloh-Hospital MRI-Institute (P.P.), Gütersloh, Germany.
Correspondence to Thomas Kohl, MD, Department of Obstetrics and Gynecology, Division of Prenatal Medicine, University of Lübeck Medical School, Ratzeburger Allee 140, 23538 Lübeck, Germany. E-mail thokohl{at}t-online.de
| Abstract |
|---|
|
|
|---|
Methods and Results We assessed the potential of a newly available 10-French phased-array intravascular ultrasound catheter for multimodal fetal transesophageal echocardiography in 5 fetal sheep between 78 and 98 days of gestation (term, 145 to 150 d). The intravascular ultrasound catheter was easily inserted through the mouth into the esophagus in all 5 sheep fetuses (mean weight, 600 g), and it permitted high-quality 2D imaging of the fetal heart in vertical imaging planes that were validated by MRI. Color Doppler and pulsed Doppler imaging permitted clear assessment of fetal cardiovascular flows and recording of velocity-time integral tracings of the fetal heart and great vessels. The vertical imaging planes were particularly useful to demonstrate interventional material inside the fetal heart and great vessels.
Conclusions Our early experience with the phased-array intravascular ultrasound catheter indicates that multimodal fetal transesophageal echocardiography has now become possible in these smallest of patients.
Key Words: fetus echocardiography ultrasonics valvuloplasty surgery catheterization fetoscopy
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
The catheter permits 2D real-time imaging and Doppler imaging and is tipped with a frequency agile 5.5 to 10 MHz vector phased-array ultrasound transducer. Tissue penetration ranges between 2 mm to >10 cm. The catheter is linked to commercially available ultrasound platforms (Acuson). In contrast to the previously used mechanical intravascular ultrasound system (Insight II, Boston Scientific), which displayed fetal cardiac anatomy in horizontal imaging planes, this novel catheter provides vertical planes. Therefore, one objective of our study was to describe and validate the transesophageal echocardiographic definition of fetal cardiac anatomy and spatial relationships in this new imaging format. In 3 fetuses, transesophageal ultrasound guidance of interventional devices that were introduced via the umbilical vein, right jugular vein, or direct ventricular puncture was tested and compared with the horizontal imaging technique of the mechanical intravascular ultrasound catheter. In addition, in all fetuses, the feasibility of pulsed and color Doppler interrogation of the fetal heart and great vessels was assessed.
After each study, the anesthetized ewe and the fetus were killed with a potassium chloride overdose. To validate the novel vertical fetal transesophageal imaging planes, 2 fetuses weighing 300 and 600 g, respectively, were perfusion-fixed with 500 mL of 4% formalin via the umbilical vein. In these fetuses, T1-weighted, 3D, gradient echo sequence MRI followed by multiplane reconstruction (PRIMA 1.0 Tesla, General Electric, Neu Isenburg, Germany) replicating the vertical transesophageal imaging planes was performed. The study protocol had been approved by the local Committee on Animal Research and was performed according to institutional guidelines.
| Results |
|---|
|
|
|---|
|
Placement of Interventional Devices
Because both ventricular outflow tracts were displayed vertically, 0.014-inch guidewires were demonstrated in a single imaging plane coursing through the respective valve and adjacent subvalvular and supravalvular areas (Figure 2). During attempts at transventricular fetal cardiac catheterization, the ultrasound catheter permitted the exact localization of blunt needle shafts that were placed onto the left ventricular epicardium and, subsequently, the visualization of the intracardiac alignment of these shafts with the left or right ventricular outflow tract.
|
Doppler Imaging
Color and pulsed Doppler imaging permitted clear assessment of fetal cardiovascular flows (Figures 1C and 1D). By adjusting the intraesophageal catheter position, pulsed Doppler interrogation at incidence angles below 10° allowed us to record good quality velocity-time integral tracings of all cardiac valves, the ascending aorta, aortic arch, bovine trunk, main and left pulmonary artery, ductus arteriosus, hepatic veins, ductus venosus, and umbilical vein. Because of their course and/or proximity to the ultrasound catheter, pulsed Doppler interrogation of the inferior caval vein, descending aorta, right pulmonary artery, pulmonary veins, and oval foramen at incidence angles below 45° was not possible.
| Discussion |
|---|
|
|
|---|
Two-Dimensional Imaging and Placement of Interventional Devices
Because of its intraesophageal position, the phased-array catheter permits 2D imaging of the fetal heart in previously unattained detail and clarity in sheep fetuses as small as 300 g. In contrast to the previously used mechanical ultrasound catheters, the higher depth penetration of the phased-array catheter permits clear definition of even the anterior margins of the fetal heart and chest. This ability allows the physician to choose the appropriate cardiac entry site for direct transventricular fetal cardiac catheterization.2 This antegrade approach aims to dilate severely obstructed fetal semilunar valves and is currently being tested by our group because it greatly reduces the technical requirements for interventional devices. Although the ultrasound catheter tip can be flexed substantially, we did not attempt fetal transgastric cardiac imaging to avoid injuring the delicate fetal esophagus and stomach.
Because the phased-array ultrasound catheter displays both ventricular outflow tracts longitudinally, the course of interventional devices through the respective semilunar valve and adjacent subvalvular and supravalvular areas can be better recognized during fetal cardiac catheterization than with using the mechanical imaging device. With the latter device, the horizontal imaging planes required constant catheter repositioning to deliver an interventional device into the fetal heart (Figure 2). In addition, because the phased-array technology permits electronic magnification of any chosen cardiac region of interest, steering interventional devices into the fetal heart can be monitored far more precisely than with the mechanical catheter, in which any increment in magnification was bought at the expense of image depth display.
Doppler Imaging
The phased-array catheter offers, for the first time, color Doppler and pulsed and continuous Doppler interrogation of the fetal heart from the esophagus, thus opening the door for detailed hemodynamic assessment during fetoscopic and open fetal cardiac interventions. By simple adjustments of the intraesophageal position of the device, low incidence angles can be achieved for most intracardiac and great vessel flow regions, thus providing the basis for accurate estimation of transvalvular pressure gradients and quantitation of valve regurgitation.
Limitations of the Device
Although the vertical imaging planes seem particularly useful for the dilation of semilunar valve obstructions, a number of fetal cardiac interventions might involve atrial septostomy or dilation of a restrictive oval foramen. The lack of transverse plane imaging might make visualization of the oval foramen more difficult. Therefore, further technical developments toward a biplane or multiplane device and the incorporation of thermal sensors are desired. To perform fetal transesophageal echocardiography in human fetuses as early as 16 weeks of gestation, a further reduction in catheter dimensions and even softer materials will be required.
| Acknowledgments |
|---|
Received June 5, 2001; revision received August 16, 2001; accepted August 17, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. D. Hoit Echocardiographic Characterization of the Cardiovascular Phenotype in Rodent Models Toxicol Pathol, January 1, 2006; 34(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J B Chambers, P R Taylor, J F Reidy, C Woods, S J Carter, and T S Padayachee Transoesophageal ultrasonography: a new approach to imaging the thoracic aorta Heart, February 1, 2005; 91(2): 245 - 246. [Full Text] [PDF] |
||||
![]() |
J. B Seward Fantastic voyage through the cardiovascular system Eur J Echocardiogr, January 1, 2004; 5(1): 8 - 11. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |